Premium
Different Metabotropic Glutamate Receptors Play Opposite Roles in Synaptic Plasticity of the Rat Medial Vestibular Nuclei
Author(s) -
Grassi Silvarosa,
Frondaroli Adele,
Pettorossi Vito Enrico
Publication year - 2002
Publication title -
the journal of physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.802
H-Index - 240
eISSN - 1469-7793
pISSN - 0022-3751
DOI - 10.1113/jphysiol.2002.023424
Subject(s) - metabotropic glutamate receptor , long term potentiation , chemistry , glutamate receptor , metabotropic glutamate receptor 5 , metabotropic receptor , antagonist , metabotropic glutamate receptor 1 , neuroscience , synaptic plasticity , pharmacology , receptor , biology , biochemistry
In the medial vestibular nuclei (MVN) of rat brainstem slices, the role of group II and III metabotropic glutamate receptors (mGluRs) and of the subtypes of group I mGluRs: mGluR1, mGluR5, was investigated in basal synaptic transmission and in the induction and maintenance of long‐term potentiation (LTP). We used selective antagonists and agonists for mGluRs and we analysed the field potentials evoked by vestibular afferent stimulation before and after high‐frequency stimulation (HFS) to induce LTP. The group II and III mGluR antagonist, ( R,S )‐α‐2‐methyl‐4sulphonophenylglycine (MSPG), induced LTP per se and caused a reduction of the paired‐pulse facilitation (PPF) ratio indicating an enhancement of glutamate release. This suggests that group II and III mGluRs are activated under basal conditions to limit glutamate release. Both the group II and III mGluR selective antagonists, 2 S ‐2‐amino‐2‐(1 S ,2 S ‐2‐carboxycycloprop‐1‐yl)‐3‐(xanth‐9‐yl)propanoate (LY341495) and ( R,S )‐α‐methylserine‐ O ‐phosphate (MSOP), induced LTP, and the selective agonists, (2 R ,4 R )‐4‐aminopyrrolidine‐2,4‐dicarboxylate (APDC) and L(+)‐2‐amino‐4‐phosphonobutyric acid (L‐AP4) depressed the field potentials and prevented HFS‐LTP, with a prevailing contribution of group II mGluRs over that of group III mGluRs. The mGluR1 antagonist, 7‐(hydroxyimino)cyclopropa[b]chromen‐1a‐carboxylate ethyl ester (CPCCOEt) prevented the full development and maintenance of HFS‐LTP. By contrast, the mGluR5 antagonist, 2‐methyl‐6‐phenylethynylpyridine (MPEP) induced LTP per se , which was impeded by CPCCOEt, and it had no effect on LTP once induced by HFS. The PPF analysis showed an enhancement of glutamate release during MPEP potentiation. The group I mGluR agonist, ( R,S )‐3,5‐dihydroxyphenylglycine (DHPG) induced LTP per se , which was blocked by CPCCOEt. By contrast the mGluR5 agonist, ( R,S )‐2‐chloro‐5‐hydroxypheylglycine (CHPG) prevented LTP elicited by HFS and DHPG as well. In conclusion vestibular LTP is inhibited by group II and III mGluRs during the early induction phase while it is facilitated by mGluR1 for achieving its full expression and consolidation. An additional inhibitory control is exerted by mGluR5 at the level of this facilitatory phase.